US FDA updates warning against widespread use of fluoroquinolones

The US Food & Drug Administration issued a warning against casual usage of fluoroquinolone antibiotics, arguably the most widely used broad-spectrum antibiotic in India. USFDA advised that the side effects caused by the use of fluoroquinolone antibacterial drugs would outweigh the benefits for patients who have alternative treatment options. Patients with acute sinusitis, acute bronchitis and uncomplicated urinary […]